IMAC Holdings Inc (BACK) USD0.001
Sell:$0.08Buy:$0.08
$0.00
(2.50%)
- This stock can be held in a
Create an alert
Stocks and Shares ISA
Fund and Share Account$0.00
(2.50%)$0.00
(2.50%)Company Information
About this company
IMAC Holdings, Inc. provides services related to proteomic products that identify and support oncology clinical treatment decisions and biopharmaceutical drug development. The Company, through its subsidiary, Ignite Proteomics LLC (Ignite Proteomics), leverages its multi-analyte proteomic assay to help oncologists pinpoint the effective targeted therapies for each patient. Its product is a patented Reverse Phase Protein Array (RPPA) technology platform, which can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. Ignite Proteomics operates a CLIA-certified and CAP-accredited laboratory and offers single-gene tests by evaluating entire protein pathways in cancer cells. Its commercially available lab developed test (LDT), the Ignite RPPA Assay for Breast Cancer, is being utilized by oncologists across the United States to assist in making the targeted treatment plan for their patients with advanced breast cancer.
Key people
Key facts
- EPICBACK
- LocationUnited States
- SectorHealthcare
- IndustryHealthcare Facilities
- ISINUS44967K3023
- Market cap$310,370.00
- Employees15
- Shares in issue3.78m
- ExchangeOver The Counter
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.